Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

30.25
+0.83002.82%
Post-market: 30.10-0.1500-0.50%18:57 EDT
Volume:3.29M
Turnover:98.04M
Market Cap:2.17B
PE:-5.13
High:30.61
Open:29.09
Low:28.46
Close:29.42
52wk High:56.05
52wk Low:23.05
Shares:71.71M
Float Shares:52.39M
Volume Ratio:1.73
T/O Rate:6.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.32
PE(LYR):-6.49

Loading ...

Vera Therapeutics Q2 Loss Widens Less than Expected

Reuters
·
Aug 11

Vera Therapeutics Q2 EPS $(1.52) Beats $(1.61) Estimate

Benzinga Earnings
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Vera Therapeutics Q2 FY26 Net Loss Widens to $109.5 Million; Loss Per Share Rises to $1.52

Reuters
·
Aug 11

Vera Therapeutics, - Anticipates Sbla Submission to FDA for Trutakna in Q4 2026

THOMSON REUTERS
·
Aug 11

Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 11

Vera Therapeutics Grants Inducement Equity Awards to New Chief Regulatory Officer, Hires

Reuters
·
Aug 08

Vera Therapeutics Names Nancy Lee Boman as Chief Regulatory Officer in Initial Beneficial Ownership Filing

Reuters
·
Aug 06

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Vera Therapeutics (VERA)

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Vera Therapeutics (VERA) and Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 13

Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (VERA), Crinetics Pharmaceuticals (CRNX) and Revolution Medicines (RVMD)

TIPRANKS
·
Jul 11

Vera Therapeutics Grants Inducement Equity Awards to Eight New Hires, Sets Options at $40.13 Per Share

Reuters
·
Jul 11

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 11

Vera Therapeutics CEO Fordyce Marshall Sells 46,250 Shares for $1.96 Million

Reuters
·
Jul 10

Vera Therapeutics Names Nancy Bowman Chief Regulatory Officer, Replacing William Turner

Reuters
·
Jul 09

Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner

THOMSON REUTERS
·
Jul 09

Vera Therapeutics' Trutakna Pricing Tops Expectations, Wedbush Says

MT Newswires Live
·
Jul 09

Vera Therapeutics (VERA) Receives a Buy from Jefferies

TIPRANKS
·
Jul 08

Remitly Stock And 2 More Growth Picks With Strong Earnings Forecasts

Simply Wall St.
·
Jul 08

Wedbush Raises Price Target on Vera Therapeutics to $43 From $35, Keeps Neutral Rating

MT Newswires Live
·
Jul 08